Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 825

1.

An Examination of the Role of Transcriptional and Posttranscriptional Regulation in Rhabdomyosarcoma.

Hron AJ, Asakura A.

Stem Cells Int. 2017;2017:2480375. doi: 10.1155/2017/2480375. Epub 2017 May 30. Review.

2.

Making muscle: skeletal myogenesis in vivo and in vitro.

Chal J, Pourquié O.

Development. 2017 Jun 15;144(12):2104-2122. doi: 10.1242/dev.151035. Review.

PMID:
28634270
3.

RNA Localization: Making its Way to the Center Stage.

Chin A, Lécuyer E.

Biochim Biophys Acta. 2017 Jun 16. pii: S0304-4165(17)30197-6. doi: 10.1016/j.bbagen.2017.06.011. [Epub ahead of print] Review.

PMID:
28630007
4.

Development of selective androgen receptor modulators (SARMs).

Narayanan R, Coss CC, Dalton JT.

Mol Cell Endocrinol. 2017 Jun 15. pii: S0303-7207(17)30340-4. doi: 10.1016/j.mce.2017.06.013. [Epub ahead of print] Review.

PMID:
28624515
5.

Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies.

Pini V, Morgan JE, Muntoni F, O'Neill HC.

Curr Stem Cell Rep. 2017;3(2):137-148. doi: 10.1007/s40778-017-0076-6. Epub 2017 Apr 24. Review.

6.

International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R, Candow DG, Kleiner SM, Almada AL, Lopez HL.

J Int Soc Sports Nutr. 2017 Jun 13;14:18. doi: 10.1186/s12970-017-0173-z. eCollection 2017. Review.

7.

Limb-girdle Muscular Dystrophies in India: A Review.

Khadilkar SV, Faldu HD, Patil SB, Singh R.

Ann Indian Acad Neurol. 2017 Apr-Jun;20(2):87-95. doi: 10.4103/aian.AIAN_81_17. Review.

8.

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.

Gee P, Xu H, Hotta A.

Stem Cells Int. 2017;2017:8765154. doi: 10.1155/2017/8765154. Epub 2017 May 15. Review.

9.

Nutritional Challenges in Duchenne Muscular Dystrophy.

Salera S, Menni F, Moggio M, Guez S, Sciacco M, Esposito S.

Nutrients. 2017 Jun 10;9(6). pii: E594. doi: 10.3390/nu9060594. Review.

10.

Normal and altered pre-mRNA processing in the DMD gene.

Tuffery-Giraud S, Miro J, Koenig M, Claustres M.

Hum Genet. 2017 Jun 9. doi: 10.1007/s00439-017-1820-9. [Epub ahead of print] Review.

PMID:
28597072
11.

In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases.

Chowdhury N, Asakura A.

Stem Cells Int. 2017;2017:3027520. doi: 10.1155/2017/3027520. Epub 2017 May 15. Review.

12.

Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series.

Papa AA, D'Ambrosio P, Petillo R, Palladino A, Politano L.

Intractable Rare Dis Res. 2017 May;6(2):95-101. doi: 10.5582/irdr.2017.01024. Review.

13.

[Risk genes in myopathies and mitochondrial diseases].

Stendel C, Walter MC, Klopstock T.

Nervenarzt. 2017 Jun 1. doi: 10.1007/s00115-017-0350-y. [Epub ahead of print] Review. German.

PMID:
28573363
14.

Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.

Nakamura A.

J Hum Genet. 2017 Jun 1. doi: 10.1038/jhg.2017.57. [Epub ahead of print] Review.

PMID:
28566768
15.

Classification of Involuntary Movements in Dogs: Myoclonus and Myotonia.

Lowrie M, Garosi L.

J Vet Intern Med. 2017 May 30. doi: 10.1111/jvim.14771. [Epub ahead of print] Review.

16.

Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Meola G, Biasini F, Valaperta R, Costa E, Cardani R.

J Neurol. 2017 May 26. doi: 10.1007/s00415-017-8504-1. [Epub ahead of print] Review.

PMID:
28550479
17.

Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.

Timpani CA, Hayes A, Rybalka E.

Orphanet J Rare Dis. 2017 May 25;12(1):100. doi: 10.1186/s13023-017-0652-y. Review.

18.

Skeletal Muscle Cell Induction from Pluripotent Stem Cells.

Kodaka Y, Rabu G, Asakura A.

Stem Cells Int. 2017;2017:1376151. doi: 10.1155/2017/1376151. Epub 2017 Apr 26. Review.

19.

The golden retriever model of Duchenne muscular dystrophy.

Kornegay JN.

Skelet Muscle. 2017 May 19;7(1):9. doi: 10.1186/s13395-017-0124-z. Review.

20.

Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.

Patel NJ, Van Dyke KW, Espinoza LR.

Am J Med Sci. 2017 May;353(5):484-491. doi: 10.1016/j.amjms.2016.05.024. Epub 2016 May 30. Review.

PMID:
28502335

Supplemental Content

Loading ...
Support Center